Comparison of 6F and 7F Sheaths for Coronary Intervention Via Distal Radial Artery Access
A Multicenter Study Comparing the Efficacy and Safety of 6F and 7F Thin-Walled Sheaths Via Distal Radial Artery Access for Coronary Intervention
1 other identifier
interventional
574
1 country
1
Brief Summary
This is a multicenter, randomized controlled, prospective, non-inferiority, open-label study aiming to evaluate whether the efficacy and safety of using a 7F thin-walled sheath via distal radial artery (dTRA) access for coronary intervention (PCI) are non-inferior to the use of a 6F thin-walled sheath. The study population includes adult patients who are candidates for coronary intervention. The primary endpoint is the rate of radial artery and distal radial artery occlusion 24 hours post-procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 2, 2024
CompletedStudy Start
First participant enrolled
September 10, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2026
CompletedFebruary 25, 2025
September 1, 2024
1.1 years
September 2, 2024
February 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Radial Artery Occlusion Rate 24 Hours Post-Procedure
The primary outcome is the rate of radial artery and distal radial artery occlusion 24 hours after the procedure. Occlusion will be determined by the absence of blood flow spectrum in the radial artery as assessed by ultrasound.
24 hours post-procedure
Secondary Outcomes (11)
Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)
Up to 30 days post-procedure
Cannulation Success Rate
During the procedure
PCI Success Rate
During the procedure
Radial Artery Occlusion Rate 30 Days Post-Procedure
30 days post-procedure
Major Bleeding Events
Up to 30 days post-procedure
- +6 more secondary outcomes
Study Arms (2)
7F Sheath Intervention Group
EXPERIMENTALParticipants in this arm will undergo coronary intervention using a 7F thin-walled sheath via distal radial artery access. This group will be used to assess the efficacy and safety of the 7F sheath compared to the 6F sheath.
6F Sheath Control Group
ACTIVE COMPARATORParticipants in this arm will undergo coronary intervention using a 6F thin-walled sheath via distal radial artery access. This group will serve as the control to compare the outcomes against those of the 7F sheath group.
Interventions
The 7F Thin-Walled Sheath is used during coronary intervention procedures via distal radial artery access. This device has a smaller outer diameter compared to traditional 7F sheaths, designed to reduce the risk of vascular complications while allowing for the performance of complex coronary interventions.
The 6F Thin-Walled Sheath is the standard device used in coronary intervention procedures via distal radial artery access. It is employed as a control in this study to compare its efficacy and safety against the 7F Thin-Walled Sheath.
Eligibility Criteria
You may qualify if:
- Age ≥18 years and ≤80 years;
- Height ≤180 cm;
- Distal radial artery diameter ≥1.7 mm;
- Completed distal radial artery angiography and requires coronary intervention;
- Tolerates dual antiplatelet therapy and intraoperative anticoagulant therapy, with no history of related drug allergies;
- Patient consents to participate in the study.
You may not qualify if:
- Acute myocardial infarction requiring emergency PCI;
- Ultrasound-confirmed occlusion of the radial artery on the procedure side;
- Radial artery and distal radial artery anomalies (e.g., small caliber, tortuous, looped vessels) that make the dTRA approach unsuitable;
- Previous bilateral radial artery intervention or surgery;
- No coronary intervention performed after coronary angiography;
- Inability to undergo coronary angiography and intervention due to subjective or objective reasons;
- Coronary lesions requiring the use of a 7F guiding catheter;
- Coronary arteries not suitable for 7F guiding catheter;
- Severe liver or renal insufficiency, unresolved bleeding disorders, or other serious conditions with an expected survival of less than 1 year;
- Currently breastfeeding or known pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fuwai Hospital, CAMS & PUMC
Beijing, Beijing Municipality, 100037, China
Related Publications (1)
Liu M, Du Y, Cui C, Li C, Yu W, Wang H, Song Y, Gao Z, Song L, Zhai J, Yang Y, Yang W, Wu Y, Liu D, Guo J, Heisha N, Liu H, Zhao Y, Zhang F, Tang Y, Zhao Y, Yu M, Zhang B, Yang J, Li R, Li H, Xiong X, Guo X, Li H, Song Y, Duan F, Gao L. Distal Radial Artery Access With 6F and 7F Thin-Walled Sheaths for Coronary Intervention: A Multicentre, Randomized, DRAWS Trial Protocol. Can J Cardiol. 2025 Dec;41(12):2420-2428. doi: 10.1016/j.cjca.2025.09.002. Epub 2025 Sep 13.
PMID: 40953816DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lijian Gao, PhD. MD.
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 2, 2024
First Posted
September 19, 2024
Study Start
September 10, 2024
Primary Completion
September 30, 2025
Study Completion
January 30, 2026
Last Updated
February 25, 2025
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share
The decision not to share individual participant data (IPD) is based on concerns related to patient confidentiality and data privacy. While all data collected in this study will be securely stored and managed, the nature of the data involves sensitive health information that could potentially identify participants. Furthermore, the current study does not have the necessary infrastructure or resources in place to manage the secure and controlled distribution of IPD to external researchers. Therefore, to protect participant privacy and adhere to ethical standards, we have decided not to share IPD for this trial.